| NAME |
EMPAGLIFLOZIN 25/LINAGLIPTIN 5/METFORMIN 1000MG TAB,SA |
| VA GENERIC NAME |
EMPAGLIFLOZIN/LINAGLIPTIN/METFORMIN |
| DOSAGE FORM |
TAB,SA |
| FDA MED GUIDE |
Empagliflozin-Linagliptin-Metformin_SA_(Trijardy_XR)_(2021).pdf |
| HAZARDOUS TO DISPOSE |
NO |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| SINGLE/MULTI SOURCE PRODUCT |
Multisource |
| NATIONAL FORMULARY NAME |
EMPAGLIFLOZIN/LINAGLIPTIN/METFORMIN TAB,SA |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
1x Possible Dosage |
| PACKAGE |
Both Inpatient and Outpatient |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2020-03-19 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
TRIJARDY 25/5/1000MG 24HR SA TAB |
| VA PRODUCT IDENTIFIER |
T1058 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
TAB |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4039227 |
| EFFECTIVE DATE/TIME |
-
- 2020-03-19 00:00:00
- STATUS: ACTIVE
|